342O Intracranial administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in recurrent glioblastoma (rGB): A multi-cohort adaptive phase I clinical trial

342O Intracranial administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in recurrent glioblastoma (rGB): A multi-cohort adaptive phase I clinical trial

Saved in:
Bibliographic Details
Published in:Annals of oncology Vol. 32; pp. S516 - S517
Main Authors: Neyns, B., Schwarze, J.K., Bertels, C., Geens, W., Tijtgat, J., Awada, G., Vaeyens, F., Cras, L., Vanbinst, A-M., Everaert, H., Michotte, A., Bruneau, M., Forsyth, R., Tuyaerts, S., Duerinck, J.
Format: Journal Article
Language:English
Published: Elsevier Ltd 01-09-2021
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0923-7534
1569-8041
DOI:10.1016/j.annonc.2021.08.006